Tom E. Howard

2.2k citations

46 papers · 1.7k indexed · 1 hit paper · h-index 18

Hematology top 2%
- Hemophilia Treatment and Research 24
- Platelet Disorders and Treatments 12
- Blood Coagulation and Thrombosis Mechanisms 9
Cardiology and Cardiovascular Medicine top 5%
- Renin-Angiotensin System Studies 5
Endocrinology, Diabetes and Metabolism top 5%
Internal Medicine top 5%
Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 9
Molecular Biology
- Protein Hydrolysis and Bioactive Peptides 6
- Cancer-related gene regulation 5

Co-authors: Kenneth E. Bernstein Mario R. Capecchi Charles R. Esther Elaine M. Marino Shaw‐Yung Shai Kimberly G. Langford Judy M. Goddard Paul A. Overbeek
Cited by: Hematology Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism
Journals: Blood (17 papers)Molecular and Cellular Biology (4 papers)Scientific Reports (1 paper)
Partner nations: United States Australia Germany

In The Last Decade

Tom E. Howard

40 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Tom E. Howard

Since Specialization

Citations

This map shows the geographic impact of Tom E. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom E. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom E. Howard more than expected).

Fields of papers citing papers by Tom E. Howard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom E. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom E. Howard. The network helps show where Tom E. Howard may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tom E. Howard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom E. Howard Line = papers co-authored together Tom E. Howard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Surgical approaches to periprosthetic femoral fractures for plate fixation or revision arthroplasty The Bone & Joint Journal ·Chloe E. H. Scott,Liam Z. Yapp,Tom E. Howard,James T. Patton,Matthew Moran	2023	7
2	Genomic variations in patients with myelodysplastic syndrome and karyotypes without numerical or structural changes Scientific Reports ·Thais De Castro De Barros,sivorad Nikolić,J. Moon,YingChen,Laysa Nobre,Xinxin He,Aparecido Divino da Cruz,Marcio Almeida,Tom E. Howard,Samar Derbali	2021	2
3	The intron-22–inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics Blood ·Zuben E. Sauna,Jay N. Lozier,Carol K. Kasper,Chen Yanover,Timothy C. Nichols,Tom E. Howard	2014	16
4	Detection of Intracellular Factor VIII Protein in Peripheral Blood Mononuclear Cells by Flow Cytometry BioMed Research International ·Stephen B. Carmody,Damisa Damisa,Tom E. Howard,Zuben E. Sauna	2013	9
5	Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon Resonance PLoS ONE ·Kenneth B. Lewis,Richard J. Hughes,Melinda S. Epstein,Neil C. Josephson,Christine L. Kempton,Craig M. Kessler,Nigel S. Key,Tom E. Howard,Rebecca Kruse‐Jarres,Jeanne M. Lusher,Christopher Walsh,Raymond G. Watts,Ruth A. Ettinger,Kathleen P. Pratt,(unknown)	2013	18
6	Polymorphisms in the F8 Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational Assessment PLoS Computational Biology ·Stephen B. Carmody,Chen Yanover,Tom E. Howard,Zuben E. Sauna	2013	26
7	The 57 kb deletion in cystinosis patients extends into TRPV1 causing dysregulation of transcription in peripheral blood mononuclear cells Journal of Medical Genetics ·Katy A. Freed,John Blangero,Tom E. Howard,Matthew P. Johnson,Joanne E. Curran,tahmineh Malek Zadeh,Qi Zenglu,H. E. Abboud,Eric K. Moses	2011	17
8	Haemophilia management: time to get personal? Haemophilia ·Tom E. Howard,Chen Yanover,Johnny Mahlangu,Amanda Krause,Kevin R. Viel,Carol K. Kasper,Kathleen P. Pratt	2011	11
9	Inhibitors of Factor VIII in Black Patients with Hemophilia New England Journal of Medicine ·Kevin R. Viel,Afshin Ameri,Thomas C. Abshire,Rathi V. Iyer,Raymond G. Watts,C.L. Lutcher,Marion Thorel,Shelley A. Cole,Karl Fernstrom,Shelley Nakaya,Carol K. Kasper,Arthur R. Thompson,Laura Almasy,Tom E. Howard	2009	134
10	Functional analysis of the genetic variability in the F7 gene promoter Atherosclerosis ·Maria Sabater‐Lleal,Miguel Chillón,Tom E. Howard,Allison Rice,Laura Almasy,John Blangero,J. Fontcuberta,José Manuel Soria	2007	23
11	A nonstop mutation in the factor (F)X gene of a severely haemorrhagic patient with complete absence of coagulation FX Thrombosis and Haemostasis ·Marion Thorel,Dorothy Milne,Karl Fernstrom,María de Lourdes Domínguez Gálvez,Alexander Duncan,Sébastien Fuchs,Afshin Ameri,Deepa Machiah,Thuy Tran,Tom E. Howard	2007	15
12	Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent. Blood ·Tom E. Howard,Kevin R. Viel,Karl Fernstrom,Seema S. Deshpande,Afshin Ameri,Mohammad Ali,Marion Thorel,Rathi V. Iyer,Raymond G. Watts,C.L. Lutcher,Shelley Nakaya,Carol K. Kasper,Arthur R. Thompson,Thomas C. Abshire,Laura Almasy	2006	1
13	Genetic determinants of normal variation in coagulation factor (F) IX levels: genome‐wide scan and examination of the FIX structural gene Journal of Thrombosis and Haemostasis ·María de Lourdes Domínguez Gálvez,Alfonso Buil,Kevin R. Viel,Sandra Porter,G-E.A. Bjørneboe,Deepa Machiah,José Manuel Soria,Juan Carlos Souto,Afshin Ameri,Mark Lathrop,John Blangero,J. Fontcuberta,Stephen T. Warren,Laura Almasy,Tom E. Howard	2006	17
14	A comparison of discrete versus continuous environment in a variance components-based linkage analysis of the COGA data BMC Genetics ·Kevin R. Viel,G-E.A. Bjørneboe,Alfonso Buil,Thomas D. Dyer,Tom E. Howard,Laura Almasy	2005	4
15	The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. Journal of Clinical Investigation ·Charles R. Esther,Eduardo L. Mariño,Tom E. Howard,Namsik Chang,Pierre Corvol,Mario R. Capecchi,Kenneth E. Bernstein	1997	234
16	A patient homozygous for a mutation in the prothrombin gene 3??? -untranslated region associated with massive thrombosis Blood Coagulation & Fibrinolysis ·Tom E. Howard,Estera Głuszko-Boczoń,Dan Smith,Alexander Duncan	1997	41
17	Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.breakdown → PubMed ·Charles R. Esther,Tom E. Howard,Elaine M. Marino,Judy M. Goddard,Mario R. Capecchi,Kenneth E. Bernstein	1996	380
18	Lessons from angiotensin-converting enzyme-deficient mice Current Opinion in Nephrology & Hypertension ·Charles R. Esther,Tom E. Howard,Yudong Zhou,Mario R. Capecchi,Mario B. Marrero,Kenneth E. Bernstein	1996	5
19	Structure and Regulated Expression of Angiotensin-Converting Enzyme and the Receptor for Angiotensin II American Journal of Kidney Diseases ·Kenneth E. Bernstein,Shaw‐Yung Shai,Tom E. Howard,Giorgos Kottis,Kristen Frenzel,Kimberly G. Langford	1993	7
20	Tissue Specific Expression of Angiotensin Converting Enzyme Birkhäuser Basel eBooks ·Kenneth E. Bernstein,Tom E. Howard,Shaw‐Yung Shai,Kimberly G. Langford,Giorgos Kottis	1992	5

About Tom E. Howard

Tom E. Howard is a scholar working on Hematology, Genetics, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 46 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (24 papers), Platelet Disorders and Treatments (12 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Protein Hydrolysis and Bioactive Peptides (6 papers), Renin-Angiotensin System Studies (5 papers), Cancer-related gene regulation (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). The work is most often cited by research in Hematology (475 citations), Cardiology and Cardiovascular Medicine (623 citations), Endocrinology, Diabetes and Metabolism (389 citations), Internal Medicine (77 citations) and Genetics (193 citations). Tom E. Howard has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Kenneth E. Bernstein, Mario R. Capecchi, Charles R. Esther, Elaine M. Marino, Shaw‐Yung Shai, Kimberly G. Langford, Judy M. Goddard, Paul A. Overbeek, Brian M. Martin and Eduardo L. Mariño. Their work appears in journals such as Blood, Molecular and Cellular Biology, Scientific Reports, Blood Coagulation & Fibrinolysis and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact